Medicared For All Logo

Deepinder Osahan in New York, New York

Home New York New York

Deepinder Osahan has Pulmonary Disease as his primary medical specialty. Their primary office is: 111 Broadway in New York, New York. There is an additional office location, for a total of two, for Deepinder Osahan that can be viewed further down.

They're a part of the: New York University medical group which has around 4,291 members. You can call their office at 212-263-9700 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended State University Of New York Downstate Medical Center and graduated in 2010 (around 14 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Deepinder Singh Osahan Office Phone and Directions

Deepinder Osahan
New York University
111 Broadway
New York, New York 10006
212-263-9700


Patient Ratings
Please rate your experience with Deepinder Osahan below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 212-263-9700


Enter a starting address:


Healthcare Info for Deepinder Osahan

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS)

Medical School: State University Of New York Downstate Medical Center
Graduation Year: 2010
The Primary Medical Specialty for Deepinder Osahan is listed as: Pulmonary Disease
Approximate Years of Experience: 14
PAC (PECOS ID)#: 8729220926
NPI #: 1649597063
NPI Created On: 04/24/2010
NPI Last Updated Listed as: 12/06/2023
Primary Taxonomy Code: 207RC0200X
License Number:
56247
Listed Gender: Male

Procedures, Services, Charges


Services and Procedures include:

  1. Insertion of central venous catheter for infusion, patient 5 years or older
  2. Measurement and graphic recording of total and timed exhaled air capacity
  3. Determination of lung volumes using gas dilution or washout
  4. Measurement of lung diffusing capacity
  5. New patient office or other outpatient visit, typically 45 minutes
  6. Established patient office or other outpatient visit, typically 15 minutes
  7. Established patient office or other outpatient, visit typically 25 minutes
  8. Initial hospital inpatient care, typically 50 minutes per day
  9. Initial hospital inpatient care, typically 70 minutes per day
  10. Subsequent hospital inpatient care, typically 25 minutes per day
  11. Subsequent hospital inpatient care, typically 35 minutes per day
  12. Critical care delivery critically ill or injured patient, first 30-74 minutes
  13. Critical care delivery critically ill or injured patient
  14. Physician telephone patient service, 11-20 minutes of medical discussion

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801664049

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801995337

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802048895

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $4

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802306659

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $0

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802397227

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802462987

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802578909

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802587005

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $0

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802690345

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $6

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802756769

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Additional Office Locations

1. New York University
259 1st St
Mineola, NY 11501
Group Members: 4,291


Enter a starting address:


Pulmonary Disease Professionals in New York

1 St Ave And 16th St
New-york, NY
Icahn School Of Medicine At Mount Sinai

1 Gustave L Levy Pl
New-york, NY
Icahn School Of Medicine At Mount Sinai

1000 10th Ave
New-york, NY
Icahn School Of Medicine At Mount Sinai

1111 Amsterdam Ave
New-york, NY
Icahn School Of Medicine At Mount Sinai

440 W 114th St
New-york, NY
Icahn School Of Medicine At Mount Sinai

1111 Amsterdam Ave
New-york, NY
Icahn School Of Medicine At Mount Sinai

Providers in New York University

1.Jennifer Abate

240 E 38th St
New York Ny 10016-2708
New York University
Nurse Practitioner

2.Nabil Abazaid

111 Broadway
New York Ny 10006-1901
New York University
Emergency Medicine

3.Valentino Abballe

16 Th St And 1st Ave
New York Ny 10003-3804
New York University
Diagnostic Radiology

4.Valentino Abballe

301 E 17th St
New York Ny 10003-3804
New York University
Diagnostic Radiology

5.Valentino Abballe

111 Broadway
New York Ny 10006-1901
New York University
Diagnostic Radiology

6.Valentino Abballe

111 Broadway
New York Ny 10006-1995
New York University
Diagnostic Radiology

View all 4,291 members of New York University medical group